Bio

For over 20 years, Brendan has employed a unique combination of business and scientific skills in a variety of entrepreneurial, venture capital and transactional roles. He currently leads Bowen’s Life Sciences practice which focuses on the BioPharma, Medical Device and Diagnostics sectors. During his tenure as a venture capitalist at Prism Ventures, Brendan built and invested in many successful private and public life science companies. In this role, he analyzed thousands of diverse opportunities, mentored hundreds of entrepreneurs, and helped bring several breakthrough technologies to market. Brendan also served as the founding Executive Vice Chancellor of Innovation and Business Development at UMass Chan Medical School where he led all business development and licensing functions and co-led many translational development activities for one of the country’s largest academic research centers. His team generated record numbers of licenses, spinouts and industry collaborations while rapidly growing and diversifying revenue sources. More recently, he co-founded AllosteRx Capital, a biotechnology venture capital firm and Delta Therapeutics, a precision immuno-oncology company, as well as advised numerous Life Sciences companies. Earlier in his career, O’Leary held operating roles at cutting-edge diagnostic and high-throughput drug discovery platform companies. He holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and a B.A. in Chemistry and Economics from Middlebury College.